Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.

ABSTRACT:

SUBMITTER: Galadanci NA 

PROVIDER: S-EPMC8697367 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature